ProQR Therapeutics Stock Forecast - Naive Prediction

PRQR Stock  USD 3.65  0.17  4.45%   
The Naive Prediction forecasted value of ProQR Therapeutics BV on the next trading day is expected to be 3.79 with a mean absolute deviation of 0.26 and the sum of the absolute errors of 15.80. ProQR Stock Forecast is based on your current time horizon. Although ProQR Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ProQR Therapeutics' systematic risk associated with finding meaningful patterns of ProQR Therapeutics fundamentals over time.
  
At this time, ProQR Therapeutics' Inventory Turnover is relatively stable compared to the past year. As of 11/19/2024, Receivables Turnover is likely to grow to 5.39, while Payables Turnover is likely to drop 0.08. . As of 11/19/2024, Common Stock Shares Outstanding is likely to drop to about 41.6 M. In addition to that, Net Loss is likely to drop to about (61.5 M).

ProQR Therapeutics Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the ProQR Therapeutics' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
2012-12-31
Previous Quarter
79 M
Current Value
89.4 M
Quarterly Volatility
41.6 M
 
Yuan Drop
 
Covid
A naive forecasting model for ProQR Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of ProQR Therapeutics BV value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

ProQR Therapeutics Naive Prediction Price Forecast For the 20th of November

Given 90 days horizon, the Naive Prediction forecasted value of ProQR Therapeutics BV on the next trading day is expected to be 3.79 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.16, and the sum of the absolute errors of 15.80.
Please note that although there have been many attempts to predict ProQR Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ProQR Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ProQR Therapeutics Stock Forecast Pattern

Backtest ProQR TherapeuticsProQR Therapeutics Price PredictionBuy or Sell Advice 

ProQR Therapeutics Forecasted Value

In the context of forecasting ProQR Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ProQR Therapeutics' downside and upside margins for the forecasting period are 0.04 and 19.63, respectively. We have considered ProQR Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.65
3.79
Expected Value
19.63
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of ProQR Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent ProQR Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.2885
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2591
MAPEMean absolute percentage error0.1017
SAESum of the absolute errors15.805
This model is not at all useful as a medium-long range forecasting tool of ProQR Therapeutics BV. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict ProQR Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for ProQR Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProQR Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.163.2218.94
Details
Intrinsic
Valuation
LowRealHigh
0.204.0319.75
Details
6 Analysts
Consensus
LowTargetHigh
3.583.934.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.14-0.14-0.14
Details

Other Forecasting Options for ProQR Therapeutics

For every potential investor in ProQR, whether a beginner or expert, ProQR Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ProQR Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ProQR. Basic forecasting techniques help filter out the noise by identifying ProQR Therapeutics' price trends.

ProQR Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProQR Therapeutics stock to make a market-neutral strategy. Peer analysis of ProQR Therapeutics could also be used in its relative valuation, which is a method of valuing ProQR Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ProQR Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ProQR Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ProQR Therapeutics' current price.

ProQR Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how ProQR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProQR Therapeutics shares will generate the highest return on investment. By undertsting and applying ProQR Therapeutics stock market strength indicators, traders can identify ProQR Therapeutics BV entry and exit signals to maximize returns.

ProQR Therapeutics Risk Indicators

The analysis of ProQR Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ProQR Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting proqr stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with ProQR Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProQR Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against ProQR Stock

  0.82MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.76GSK GlaxoSmithKline PLC ADRPairCorr
  0.71OGN OrganonPairCorr
  0.66A Agilent Technologies Earnings Call This WeekPairCorr
  0.66AZN AstraZeneca PLC ADRPairCorr
The ability to find closely correlated positions to ProQR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProQR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProQR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProQR Therapeutics BV to buy it.
The correlation of ProQR Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProQR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProQR Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProQR Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for ProQR Stock Analysis

When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.